Schedule 13D ownership disclosure

NovaBay Pharmaceuticals Inc

Common Stock, $0.01 par value · CUSIP: 66987P409

Event date: 2025-10-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • R01 Fund LPReported CIK 0001990517

    Shares: 1,164,117.00 · Class: 16.2%

  • R01 Capital LLC

    Shares: 1,164,117.00 · Class: 16.2%

  • R01 Capital Manager LLC

    Shares: 1,164,117.00 · Class: 16.2%

  • Michael Kazley

    Shares: 1,164,117.00 · Class: 16.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001829126-25-008156
Form type
SCHEDULE 13D
Filer
Stablecoin Development Corp
CIK
CIK 1389545
Filed
Oct 15, 2025
Reporting period
Oct 09, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub